Key result
The Charlson comorbidity index was associated with 24-month mortality but did not improve risk prediction over the GRACE-score.
Why the study?
ACS is associated with high mortality, and the authors sought to re-evaluate the performance of the Charlson comorbidity index and its components in a modern setting.
Does the Charlson Comorbidity Index improve mortality risk prediction compared to the GRACE score in patients with acute coronary syndrome?
Cohort (n=1,576)
No
Does the Charlson Comorbidity Index improve mortality risk prediction compared to the GRACE score in patients with acute coronary syndrome?
The Charlson Comorbidity Index does not provide significant incremental prognostic value over the GRACE score for predicting mortality up to 2 years in patients with acute coronary syndrome.
Answers are grounded in this paper and cite their sources.
No incremental value over GRACE for ACS mortality prediction; leaves open whether comorbidity indices refine existing scores.
Objectives. Acute coronary syndrome (ACS) is associated with high mortality. Charlson comorbidity index (CCI) was designed over 30 years ago to measure the impact of pre-existing comorbidities on long-term survival of the patient. We wanted to re-evaluate the performance of CCI and its components in modern setting. Design. This is a retrospective study of 1576 consecutive patients undergoing invasive evaluation and treated for ACS in single tertiary center between 2015–2016. Mortality was analyzed in timeframes of 1, 6 and 24 months. CCI-scores were retrieved from written medical records and complimented with data from electronic sources. The performance of CCI and its components was compared to the GRACE-score measuring patients’ status upon hospital admission. Results. Population mean age at baseline was 69.3 (SD 11.8) years and 69.1% of the patients were male (n = 1089). Most of the components of CCI associated significantly with mortality at all timeframes despite adjusting for age but only diabetes and congestive heart failure associated with mortality at all time points after adjusting for GRACE-score. CCI associated with mortality [GRACE adjusted HR-values of single unit increase of CCI after 1, 6 and 24-month follow-up: 1.12(95% CI:1.00–1.25), 1.17(1.07–1.29) and 1.24(1.16–1.33)]. CCI performed modestly with its AUC-values ranging between 0.755 and 0.784, with prognostic performance increasing with longer follow-up. Adding components of CCI did not significantly improve risk prediction over GRACE-score. Conclusions. In conclusion, CCI or its individual components measuring the impact of comorbidities on overall mortality does not provide any significant value compared to GRACE–score during up to 2 years of follow-up.
No takes yet. Share an insight, caveat, or question.
Hautamäki et al. (2019) conducted a cohort in Acute coronary syndrome (n=1,576). Charlson comorbidity index (CCI) vs. GRACE-score was evaluated on Mortality (HR 1.24, 95% CI 1.16-1.33). The Charlson comorbidity index was associated with 24-month mortality but did not improve risk prediction over the GRACE-score.
Synapse has enriched 10 related papers. Consider them for comparative context: